aristolochic acid i has been researched along with thapsigargin in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Huang, JK; Jan, CR | 1 |
Jan, CR; Tseng, CJ | 1 |
Cheng, JS; Chou, KJ; Jan, CR; Lee, KC; Tang, KY; Tseng, LL; Wang, JL | 1 |
Chen, JF; Hu, DN; Sheu, SJ; Wu, SN | 1 |
Chang, HT; Chen, IS; Chou, CT; Ho, CM; Huang, JK; Jan, CR; Kuo, CC; Liao, WC; Lin, KL; Liu, SI; Lu, YC; Shu, SS; Tsai, JY; Wang, JL | 1 |
Chen, FA; Jan, CR; Kuo, CC; Kuo, DH; Shieh, P; Tsai, JY | 1 |
Chang, KH; Chen, FA; Jan, CR; Kuo, CC; Kuo, DH; Shieh, P; Tan, HP | 1 |
8 other study(ies) available for aristolochic acid i and thapsigargin
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
AA-861-induced Ca(2+) mobilization in Madin Darby canine kidney cells.
Topics: Animals; Aristolochic Acids; Benzoquinones; Calcium; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cells, Cultured; Dogs; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Enzyme Inhibitors; Fluorometry; Inositol 1,4,5-Trisphosphate; Kidney; Lipoxygenase Inhibitors; Lysosomes; Phenanthrenes; Phospholipases A; Thapsigargin; Time Factors; Uncoupling Agents | 1999 |
W-7 induces [Ca(2+)](i) increases in Madin-Darby canine kidney (MDCK) cells.
Topics: Animals; Aristolochic Acids; Calcium; Calcium Signaling; Calmodulin; Cells, Cultured; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Estrenes; Fluorescence; Fura-2; Hydrazones; Kidney; Phenanthrenes; Propranolol; Pyrrolidinones; Sulfonamides; Thapsigargin; Time Factors | 2000 |
Novel effects of 5,8,11-eicosatriynoic acid, a lipoxygenase inhibitor, on Ca2+ mobilization in Madin Darby canine kidney cells.
Topics: Animals; Aristolochic Acids; Calcium; Calcium Signaling; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cells, Cultured; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Unsaturated; Kidney; Phenanthrenes; Plant Extracts; Thapsigargin; Type C Phospholipases | 2001 |
The influence of hypotonicity on large-conductance calcium-activated potassium channels in human retinal pigment epithelial cells.
Topics: Alkaloids; Aristolochic Acids; Benzylisoquinolines; Calcium; Calcium Channel Blockers; Cell Membrane Permeability; Cell Size; Cells, Cultured; Humans; Hypotonic Solutions; Indoles; Lactones; Membrane Potentials; Ophthalmic Solutions; Osmolar Concentration; Patch-Clamp Techniques; Peptides; Pertussis Toxin; Pigment Epithelium of Eye; Potassium; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Signal Transduction; Thapsigargin | 2004 |
Effect of thapsigargin on Ca²+ fluxes and viability in human prostate cancer cells.
Topics: Apoptosis; Aristolochic Acids; Calcium; Calcium Signaling; Cell Line, Tumor; Cell Survival; Estrenes; Fluorescence; Fura-2; Humans; Intracellular Space; Male; Manganese; Prostatic Neoplasms; Pyrrolidinones; Thapsigargin; Type C Phospholipases | 2011 |
Effect of m-3M3FBS on Ca²⁺ movement in PC3 human prostate cancer cells.
Topics: Adenocarcinoma; Aristolochic Acids; Calcium; Calcium Channel Blockers; Calcium Signaling; Cell Line, Tumor; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Humans; Indoles; Male; Models, Animal; Phospholipase A2 Inhibitors; Prostatic Neoplasms; Sulfonamides; Thapsigargin; Type C Phospholipases | 2010 |
Effect of nortriptyline on Ca²⁺ handling in SIRC rabbit corneal epithelial cells.
Topics: Animals; Antidepressive Agents, Tricyclic; Aristolochic Acids; Calcium; Calcium Channel Blockers; Calcium Signaling; Cells, Cultured; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Epithelium, Corneal; Estrenes; Models, Animal; Nortriptyline; Phosphodiesterase Inhibitors; Phospholipase A2 Inhibitors; Pyrrolidinones; Rabbits; Thapsigargin; Time Factors; Type C Phospholipases | 2010 |